BC Week In Review | Jan 9, 2012
Financial News

Radient Pharmaceuticals financial update

Radient's board authorized a 1-for-25 reverse stock split effective on or before Jan. 15. Following the split, the company will have 41.6 million shares outstanding. Radient Pharmaceuticals Corp. (OTCQX:RXPC), Tustin, Calif.   Business: Diagnostic  ...
BC Week In Review | Jan 2, 2012
Company News

Radient Pharmaceuticals, Uni Pharma sales and marketing update

Radient added Singapore, Hong Kong and Macau to an August 2011 deal granting Uni Pharma exclusive distribution rights to Radient's Onko-Sure in vitro cancer diagnostic in Taiwan. Uni Pharma will be responsible for regulatory approval...
BC Week In Review | Dec 12, 2011
Financial News

Radient Pharmaceuticals completes warrant exercise

Radient Pharmaceuticals Corp. (OTCQX:RXPC), Tustin, Calif.   Business: Diagnostic   Date completed: 12/1/11   Type: Warrant exercise   Raised: $500,000   Shares: 50,000   Price: $10.00   Shares outstanding prior: 747.8 million   Note: The...
BC Week In Review | Jun 27, 2011
Financial News

Radient Pharmaceuticals financial update

Radient was delisted from NYSE Amex for failure to comply with the exchange's listing requirements. The company is now listed on the OTCQX under "RXPC." Radient Pharmaceuticals Corp. (OTCQX:RXPC), Tustin, Calif.   Business: Diagnostic  ...
BC Week In Review | May 2, 2011
Financial News

Radient Pharmaceuticals financial update

Radient received notice that NYSE Amex has extended to June 23 the deadline to regain compliance with requirements for continued listing. Radient Pharmaceuticals Corp. (NYSE-A:RPC), Tustin, Calif.   Business: Diagnostic   Date announced: 4/21/11  ...
BC Week In Review | Mar 28, 2011
Financial News

Radient Pharmaceuticals financial update

Radient Pharmaceuticals received notice from NYSE Amex indicating that the company omitted material information in a written submission to the exchange in support of its pending appeal of a Staff's determination. *** Radient Pharmaceuticals Corp....
BC Week In Review | Feb 14, 2011
Financial News

Radient Pharmaceuticals completes private placement of convertible debentures and warrants

Radient Pharmaceuticals Corp. (NYSE-A:RPC), Tustin, Calif.   Business: Diagnostic   Date completed: 2/3/11   Type: Private placement of convertible debentures and warrants   Raised: $900,000   Shares outstanding prior: 36.8 million   Investors: Accredited investors...
BC Week In Review | Feb 7, 2011
Financial News

Radient Pharmaceuticals completes private placement of convertible notes and warrants

Radient Pharmaceuticals Corp. (NYSE-A:RPC), Tustin, Calif.   Business: Diagnostic   Date completed: 1/31/11   Type: Private placement of convertible notes and warrants   Raised: $8.4 million   Placement agent: Reedland Capital Partners   Investors: Accredited...
BC Week In Review | Jan 31, 2011
Company News

Radient Pharmaceuticals, University of Florida deal

Radient's subsidiary NuVax Therapeutics Inc. received exclusive, worldwide rights to use and commercialize four patented immune-gene therapy tools and systems from the university. NuVax plans to use the technology to selectively target patient tumor cells...
BC Week In Review | Jan 17, 2011
Company News

Jaiva Technologies Inc., Radient Pharmaceuticals sales and marketing update

Radient, Jaiva and Jaiva's Gaur Diagno Pvt. Ltd. subsidiary launched a cancer education and screening program in India using Radient's Onko-Sure in vitro diagnostic for cancer. The partners will deploy mobile cancer screening units and...
Items per page:
1 - 10 of 83
BC Week In Review | Jan 9, 2012
Financial News

Radient Pharmaceuticals financial update

Radient's board authorized a 1-for-25 reverse stock split effective on or before Jan. 15. Following the split, the company will have 41.6 million shares outstanding. Radient Pharmaceuticals Corp. (OTCQX:RXPC), Tustin, Calif.   Business: Diagnostic  ...
BC Week In Review | Jan 2, 2012
Company News

Radient Pharmaceuticals, Uni Pharma sales and marketing update

Radient added Singapore, Hong Kong and Macau to an August 2011 deal granting Uni Pharma exclusive distribution rights to Radient's Onko-Sure in vitro cancer diagnostic in Taiwan. Uni Pharma will be responsible for regulatory approval...
BC Week In Review | Dec 12, 2011
Financial News

Radient Pharmaceuticals completes warrant exercise

Radient Pharmaceuticals Corp. (OTCQX:RXPC), Tustin, Calif.   Business: Diagnostic   Date completed: 12/1/11   Type: Warrant exercise   Raised: $500,000   Shares: 50,000   Price: $10.00   Shares outstanding prior: 747.8 million   Note: The...
BC Week In Review | Jun 27, 2011
Financial News

Radient Pharmaceuticals financial update

Radient was delisted from NYSE Amex for failure to comply with the exchange's listing requirements. The company is now listed on the OTCQX under "RXPC." Radient Pharmaceuticals Corp. (OTCQX:RXPC), Tustin, Calif.   Business: Diagnostic  ...
BC Week In Review | May 2, 2011
Financial News

Radient Pharmaceuticals financial update

Radient received notice that NYSE Amex has extended to June 23 the deadline to regain compliance with requirements for continued listing. Radient Pharmaceuticals Corp. (NYSE-A:RPC), Tustin, Calif.   Business: Diagnostic   Date announced: 4/21/11  ...
BC Week In Review | Mar 28, 2011
Financial News

Radient Pharmaceuticals financial update

Radient Pharmaceuticals received notice from NYSE Amex indicating that the company omitted material information in a written submission to the exchange in support of its pending appeal of a Staff's determination. *** Radient Pharmaceuticals Corp....
BC Week In Review | Feb 14, 2011
Financial News

Radient Pharmaceuticals completes private placement of convertible debentures and warrants

Radient Pharmaceuticals Corp. (NYSE-A:RPC), Tustin, Calif.   Business: Diagnostic   Date completed: 2/3/11   Type: Private placement of convertible debentures and warrants   Raised: $900,000   Shares outstanding prior: 36.8 million   Investors: Accredited investors...
BC Week In Review | Feb 7, 2011
Financial News

Radient Pharmaceuticals completes private placement of convertible notes and warrants

Radient Pharmaceuticals Corp. (NYSE-A:RPC), Tustin, Calif.   Business: Diagnostic   Date completed: 1/31/11   Type: Private placement of convertible notes and warrants   Raised: $8.4 million   Placement agent: Reedland Capital Partners   Investors: Accredited...
BC Week In Review | Jan 31, 2011
Company News

Radient Pharmaceuticals, University of Florida deal

Radient's subsidiary NuVax Therapeutics Inc. received exclusive, worldwide rights to use and commercialize four patented immune-gene therapy tools and systems from the university. NuVax plans to use the technology to selectively target patient tumor cells...
BC Week In Review | Jan 17, 2011
Company News

Jaiva Technologies Inc., Radient Pharmaceuticals sales and marketing update

Radient, Jaiva and Jaiva's Gaur Diagno Pvt. Ltd. subsidiary launched a cancer education and screening program in India using Radient's Onko-Sure in vitro diagnostic for cancer. The partners will deploy mobile cancer screening units and...
Items per page:
1 - 10 of 83